Compare Gap Inc (GAP) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gap Inc vs Mesoblast Limited — how do they compare? Gap Inc trades at $20.28 (market cap $7.30B), while Mesoblast Limited trades at $19 (market cap $2.31B). The key difference: Gap Inc is far larger — about 3.2× Mesoblast Limited's market cap, and Gap Inc pays a 3.45% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| GAP | MESO | |
|---|---|---|
Market Cap | $7.30B | $2.31B |
Sector | Consumer Cyclical | Technology |
52-Week High | $29.13 | $20.96 |
52-Week Low | $18.35 | $11.35 |
Enterprise Value | $10.38B | $2.32B |
Dividend Yield | 3.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
